CANTANHEDE, Portugal, March 14, 2024 (GLOBE NEWSWIRE) — Tilray Manufacturers, Inc. (“Tilray” or the “Firm”) (Nasdaq: TLRY; TSX: TLRY), a world hashish and shopper packaged items firm that evokes and empowers the worldwide group to reside their lives higher, immediately introduced a breakthrough within the medical hashish trade in Portugal. Following the profitable approval of our Tilray THC 18 flower, Tilray Medical has now acquired approval for the primary medical hashish extract, Tilray Oral Resolution THC 5 CBD 20, in Portugal, marking a big milestone within the availability of medical hashish and affected person care within the nation. .

Denise Faltischek, Chief Technique Officer and Head of Worldwide at Tilray Manufacturers, Inc., stated: “It is a monumental step ahead for affected person care in Portugal. With the approval of our first medical hashish extract, We’re proud to be on the forefront of medical hashish analysis and accessibility and proceed to display our dedication to offering sufferers with progressive, protected and efficient therapeutic choices. We proceed to pioneer the way forward for medical hashish, strengthening our mission to empower and encourage people to reside their greatest lives.”

This landmark approval, confirmed on March 11, 2024, underscores Tilray's dedication to increasing protected and controlled entry to medical hashish for sufferers in want. The newly accepted medical hashish extract was launched on the finish of spring, providing new therapeutic choices for sufferers all through Portugal with particular medical circumstances. The accepted extract is indicated to be used in a number of essential affected person care areas.

Tilray Medical continues to be a world chief within the medical hashish trade, providing a various portfolio of EU-GMP licensed medicinal hashish merchandise. With operations spanning greater than 20 international locations, Tilray Medical is devoted to supporting medical hashish affected person care worldwide via high quality merchandise accessible to healthcare practitioners.

Source link